Empowered Funds LLC reduced its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 8.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 63,951 shares of the company’s stock after selling 5,651 shares during the quarter. Empowered Funds LLC’s holdings in Colgate-Palmolive were worth $5,814,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of CL. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. Hager Investment Management Services LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $36,000. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $42,000. Synergy Asset Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter worth approximately $49,000. Finally, Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the third quarter worth approximately $53,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on CL shares. Raymond James restated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Stock Up 1.6 %
CL stock opened at $87.35 on Wednesday. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The company has a market capitalization of $71.37 billion, a price-to-earnings ratio of 24.82, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The business’s 50 day moving average price is $90.14 and its two-hundred day moving average price is $96.69. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business earned $0.87 EPS. As a group, analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- How to Short a Stock in 5 Easy StepsÂ
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.